Target intelligence / Profile preview

Long intergenic non-protein coding RNA 3075 (LINC03075)

Target
LINC03075
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA (lincRNA), Non-protein coding RNA, Other
01

Overview

Long intergenic non-protein coding RNA 3075 (LINC03075) is a member of the long non-coding RNA (lncRNA) family, specifically classified as a long intergenic non-coding RNA (lincRNA), meaning it is transcribed from the genome but does not code for a protein and does not overlap with annotated coding genes[1][3][5]. LincRNAs such as LINC03075 are typically longer than 200 nucleotides and are known to participate in the regulation of gene expression at transcriptional and chromatin levels, modulate chromatin architecture, and act as regulatory RNAs affecting neighboring or distant genes, often in a tissue-specific manner[3][5]. At present, there is no direct evidence that LINC03075 is a validated therapeutic target, nor are there drugs known to interact with it or mechanisms of action attributed to targeting this RNA specifically[1]. Its specific biological role and involvement in any disease, including cancer, have yet to be definitively characterized in the scientific literature[1].

Other names
LINC03075long intergenic non-protein coding RNA 3075
02

Biological functions

Regulation of gene expressionChromatin remodelingRNA stabilizationTranscriptional regulationOther
03

Disease associations

Other

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 3075 (LINC03075).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 3075 (LINC03075).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call